MyFinsight
Home
Blog
About
Contact
Short-term investments
$8,959,614
Cash and cash
equivalents
$8,149,015
Prepaid expenses
$1,223,534
Other current assets
$234,806
Total current assets
$18,566,969
Property and equipment,
net
$756,077
Operating lease
right-of-use asset
$57,781
Other assets
$35,909
Total assets
$19,416,736
Total liabilities and
stockholders equity
$19,416,736
Total liabilities
$10,404,932
Total stockholders
equity
$9,011,804
Accumulated deficit
-$199,383,847
Total current
liabilities
$10,404,932
Additional
paid-in-capital
$208,360,523
Common stock, 0.001 par
value 100,000,000...
$35,128
Accounts payable
$3,936,948
Other current
liabilities
$3,347,515
Estimate for accrued
legal contingencies...
$2,574,759
Insurance premium loan
payable
$250,338
Accrued payroll
liabilities
$234,392
Operating lease
liability, current portion
$60,980
Back
Back
Balance Sheet
Skye Bioscience, Inc. (SKYE)
Skye Bioscience, Inc. (SKYE)
source: myfinsight.com